Found 9 matching trials
Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
PHASE1This phase 1/2, multicenter, randomized, double-blind, placebo-controlled t...
Location
Multiple Locations
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)
PHASE2The purpose of this protocol is to allow continued treatment with conatumum...
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
PHASE1This is a multi-center, phase 1b study of AMG 655 in combination with borte...
Location
Multiple Locations
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
PHASE1This is a multi-center, 2-part study of AMG 655, AMG 479 or AMG 655-placebo...
QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma
PHASE2This is a phase 2, multicenter, randomized, double-blind, double-dummy, pla...
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors
PHASE1This is a multi-center, 2-part phase 1b/2 study of AMG 655 in combination w...
Location
Multiple Locations
A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
PHASE1Part 1 is complete. Part 2 is a multi-center, randomized, double-blind, pla...
Location
Multiple Locations
Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study
PHASE1This is an exploratory phase 1b/2, global, multicenter, single-arm, 2-part ...
Location
Multiple Locations
Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
PHASE1This phase 1/2, multi-center, randomized, double-blind, placebo-controlled ...